Scientific letter
Benign multiple sclerosis, old age, and cognitive impairment: Is teriflunomide an appropriate treatment for this clinical triad?
Esclerosis múltiple benigna, edad avanzada y deterioro cognitivo: ¿una tríada clínica adecuada para el tratamiento con teriflunomida?
D.A. García Estévez
Corresponding author
Servicio de Neurología, Complexo Hospitalario Universitario de Ourense, Spain
Read
2709
Timeswas read the article
534
Total PDF
2175
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 90 | 37 | 127 |
| 2025 11 | 79 | 43 | 122 |
| 2025 10 | 39 | 19 | 58 |
| 2025 9 | 40 | 20 | 60 |
| 2025 8 | 38 | 16 | 54 |
| 2025 7 | 38 | 11 | 49 |
| 2025 6 | 44 | 6 | 50 |
| 2025 5 | 43 | 4 | 47 |
| 2025 4 | 43 | 6 | 49 |
| 2025 3 | 43 | 6 | 49 |
| 2025 2 | 27 | 2 | 29 |
| 2025 1 | 34 | 6 | 40 |
| 2024 12 | 28 | 6 | 34 |
| 2024 11 | 43 | 0 | 43 |
| 2024 10 | 20 | 5 | 25 |
| 2024 9 | 27 | 8 | 35 |
| 2024 8 | 32 | 5 | 37 |
| 2024 7 | 15 | 8 | 23 |
| 2024 6 | 25 | 5 | 30 |
| 2024 5 | 16 | 4 | 20 |
| 2024 4 | 31 | 3 | 34 |
| 2024 3 | 20 | 10 | 30 |
| 2024 2 | 19 | 4 | 23 |
| 2024 1 | 11 | 5 | 16 |
| 2023 12 | 22 | 9 | 31 |
| 2023 11 | 29 | 7 | 36 |
| 2023 10 | 26 | 15 | 41 |
| 2023 9 | 14 | 1 | 15 |
| 2023 8 | 12 | 3 | 15 |
| 2023 7 | 17 | 3 | 20 |
| 2023 6 | 15 | 5 | 20 |
| 2023 5 | 23 | 4 | 27 |
| 2023 4 | 56 | 2 | 58 |
| 2023 3 | 52 | 10 | 62 |
| 2023 2 | 23 | 4 | 27 |
| 2023 1 | 20 | 13 | 33 |
| 2022 12 | 20 | 16 | 36 |
| 2022 11 | 23 | 15 | 38 |
| 2022 10 | 21 | 15 | 36 |
| 2022 9 | 15 | 17 | 32 |
| 2022 8 | 23 | 12 | 35 |
| 2022 7 | 31 | 10 | 41 |
| 2022 6 | 57 | 11 | 68 |
| 2022 5 | 45 | 15 | 60 |
| 2022 4 | 37 | 8 | 45 |
| 2022 3 | 32 | 8 | 40 |
| 2022 2 | 46 | 6 | 52 |
| 2022 1 | 54 | 3 | 57 |
| 2021 12 | 515 | 12 | 527 |
| 2021 11 | 34 | 17 | 51 |
| 2021 10 | 42 | 15 | 57 |
| 2021 9 | 26 | 15 | 41 |
| 2021 8 | 0 | 1 | 1 |
| 2021 7 | 0 | 9 | 9 |
| 2021 6 | 0 | 14 | 14 |
Show all
